107 related articles for article (PubMed ID: 15837383)
1. Identification of an essential glycoprotease in Staphylococcus aureus.
Zheng L; Yang J; Landwehr C; Fan F; Ji Y
FEMS Microbiol Lett; 2005 Apr; 245(2):279-85. PubMed ID: 15837383
[TBL] [Abstract][Full Text] [Related]
2. Conditional mutation of an essential putative glycoprotease eliminates autolysis in Staphylococcus aureus.
Zheng L; Yu C; Bayles K; Lasa I; Ji Y
J Bacteriol; 2007 Apr; 189(7):2734-42. PubMed ID: 17237169
[TBL] [Abstract][Full Text] [Related]
3. Identification of essential genes in Staphylococcus aureus by construction and screening of conditional mutant library.
Yin D; Ji Y
Methods Mol Biol; 2008; 416():297-305. PubMed ID: 18392975
[TBL] [Abstract][Full Text] [Related]
4. A Staphylococcus aureus fitness test platform for mechanism-based profiling of antibacterial compounds.
Donald RG; Skwish S; Forsyth RA; Anderson JW; Zhong T; Burns C; Lee S; Meng X; LoCastro L; Jarantow LW; Martin J; Lee SH; Taylor I; Robbins D; Malone C; Wang L; Zamudio CS; Youngman PJ; Phillips JW
Chem Biol; 2009 Aug; 16(8):826-36. PubMed ID: 19716473
[TBL] [Abstract][Full Text] [Related]
5. Techniques for the isolation and use of conditionally expressed antisense RNA to achieve essential gene knockdowns in Staphylococcus aureus.
Forsyth A; Wang L
Methods Mol Biol; 2008; 416():307-21. PubMed ID: 18392976
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of Staphylococcus aureus gene expression and growth using antisense peptide nucleic acids.
Nekhotiaeva N; Awasthi SK; Nielsen PE; Good L
Mol Ther; 2004 Oct; 10(4):652-9. PubMed ID: 15451449
[TBL] [Abstract][Full Text] [Related]
7. Validation of antibacterial mechanism of action using regulated antisense RNA expression in Staphylococcus aureus.
Ji Y; Yin D; Fox B; Holmes DJ; Payne D; Rosenberg M
FEMS Microbiol Lett; 2004 Feb; 231(2):177-84. PubMed ID: 14987762
[TBL] [Abstract][Full Text] [Related]
8. Identification of critical staphylococcal genes using conditional phenotypes generated by antisense RNA.
Ji Y; Zhang B; Van SF; Horn ; Warren P; Woodnutt G; Burnham MK; Rosenberg M
Science; 2001 Sep; 293(5538):2266-9. PubMed ID: 11567142
[TBL] [Abstract][Full Text] [Related]
9. Identification of antimicrobial compounds active against intracellular Staphylococcus aureus.
Malouin F; Brouillette E; Martinez A; Boyll BJ; Toth JL; Gage JL; Allen NE
FEMS Immunol Med Microbiol; 2005 Aug; 45(2):245-52. PubMed ID: 15963705
[TBL] [Abstract][Full Text] [Related]
10. Polyamine effects on antibiotic susceptibility in bacteria.
Kwon DH; Lu CD
Antimicrob Agents Chemother; 2007 Jun; 51(6):2070-7. PubMed ID: 17438056
[TBL] [Abstract][Full Text] [Related]
11. Global transcriptional response of Staphylococcus aureus to rhein, a natural plant product.
Yu L; Xiang H; Fan J; Wang D; Yang F; Guo N; Jin Q; Deng X
J Biotechnol; 2008 Jun; 135(3):304-8. PubMed ID: 18514345
[TBL] [Abstract][Full Text] [Related]
12. Antimicrobial activity of a novel peptide deformylase inhibitor, LBM415, tested against respiratory tract and cutaneous infection pathogens: a global surveillance report (2003-2004).
Watters AA; Jones RN; Leeds JA; Denys G; Sader HS; Fritsche TR
J Antimicrob Chemother; 2006 May; 57(5):914-23. PubMed ID: 16549511
[TBL] [Abstract][Full Text] [Related]
13. Tigecycline in vitro activity against gram-negative and gram-positive pathogens collected in Italy.
Roveta S; Marchese A; Debbia EA
Chemotherapy; 2008; 54(1):43-9. PubMed ID: 18073470
[TBL] [Abstract][Full Text] [Related]
14. Dual antibacterial mechanisms of nisin Z against Gram-positive and Gram-negative bacteria.
Kuwano K; Tanaka N; Shimizu T; Nagatoshi K; Nou S; Sonomoto K
Int J Antimicrob Agents; 2005 Nov; 26(5):396-402. PubMed ID: 16226432
[TBL] [Abstract][Full Text] [Related]
15. A chiral benzoquinolizine-2-carboxylic acid arginine salt active against vancomycin-resistant Staphylococcus aureus.
de Souza NJ; Gupte SV; Deshpande PK; Desai VN; Bhawsar SB; Yeole RD; Shukla MC; Strahilevitz J; Hooper DC; Bozdogan B; Appelbaum PC; Jacobs MR; Shetty N; Patel MV; Jha R; Khorakiwala HF
J Med Chem; 2005 Aug; 48(16):5232-42. PubMed ID: 16078842
[TBL] [Abstract][Full Text] [Related]
16. Antibacterial antisense.
Geller BL
Curr Opin Mol Ther; 2005 Apr; 7(2):109-13. PubMed ID: 15844617
[TBL] [Abstract][Full Text] [Related]
17. The bactericidal activity of ofloxacin against staphylococci.
Lewin CS; Smith JT
J Chemother; 1989 Jul; 1(4 Suppl):151-3. PubMed ID: 16312348
[No Abstract] [Full Text] [Related]
18. Identification of suitable internal controls to study expression of a Staphylococcus aureus multidrug resistance system by quantitative real-time PCR.
Theis T; Skurray RA; Brown MH
J Microbiol Methods; 2007 Aug; 70(2):355-62. PubMed ID: 17590462
[TBL] [Abstract][Full Text] [Related]
19. Antimicrobial activity of tigecycline tested against organisms causing community-acquired respiratory tract infection and nosocomial pneumonia.
Fritsche TR; Sader HS; Stilwell MG; Dowzicky MJ; Jones RN
Diagn Microbiol Infect Dis; 2005 Jul; 52(3):187-93. PubMed ID: 16105563
[TBL] [Abstract][Full Text] [Related]
20. Antibacterial evaluation of 1,4-benzoquinone derivatives.
Lana EJ; Carazza F; Takahashi JA
J Agric Food Chem; 2006 Mar; 54(6):2053-6. PubMed ID: 16536574
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
